Status:
COMPLETED
Communication Training for Cancer Patients, Their Caregivers, and Their Doctors
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Communication and Illness Understanding
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to develop and test a new communication intervention, "Values and Options in Cancer Care 2.0" (VOICE 2.0), which involves oncologist training, patient and caregiver coachi...
Eligibility Criteria
Inclusion
- ONCOLOGISTS:
- As per self-report, medical oncologist providing care to patients with gastrointestinal, genitourinary, gynecologic, lung, or hematologic cancers at MSK
- As per self-report, not planning to leave MSK in the next six months
- As per self-report, willing to be audio-recorded for Post-Training Follow-Up Interview
- PATIENTS:
- Per medical record and/or self-report, a patient of an oncologist participating in this study
- As per medical record and/or self-report, diagnosis of:
- a hematologic cancer with disease progression following second-line treatment that is not eligible for transplant; OR
- stage III or IV gastrointestinal, genitourinary, gynecologic, or lung cancer
- As per medical record and/or self-report, fluent in English
- As per medical record and/or self-report, age 18 or older
- As per self-report, has a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) who is willing and able to participate in the study
- As per self-report, residency in New York or ability to complete sessions in New York to ensure that provision of intervention is covered by the professional licenses of interventionists (i.e., social workers licensed in New York State)
- As per self-report, able to communicate over video-conference and phone for sessions
- As per self-report, willing to be audio-recorded for assessments and study sess
- CAREGIVERS:
- As per patient report, is a primary informal caregiver ("a family member, partner, friend, or other individual involved with your health care issues, preferably someone who comes to physician appointments with you") for an MSK patient
- As per self-report, fluent in English
- As per self-report, age 18 or older
- As per self-report, ability to complete sessions in a state the interventionists are legally allowed to practice in (i.e., social workers licensed in New York or New Jersey State; states with shared license laws)
- As per self-report, able to communicate over video-conference and phone for sessions
- As per self-report, willing to be audio-recorded for assessments and study sessions \*\* Language verification: For both patients and caregivers, prior to enrollment, all will be asked the following two questions by an CRC to verify English fluency necessary for participation in the study:
- How well do you speak English? (must respond "Very well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
- What is your preferred language for healthcare? (must respond English)
Exclusion
- PATIENTS:
- Score \>4 on Short Portable Mental Status Questionnaire
- As per self-report, feels too weak or cognitively impaired to participate in the intervention and complete the assessments
- As per medical record or self-report, receiving hospice care at the time of enrollment
- CAREGIVERS:
- Score \>4 on Short Portable Mental Status Questionnaire
- As per self-report, feels too weak or cognitively impaired to participate in the intervention and complete the assessments
- As per medical record or self-report, receiving hospice care at the time of enrollment
- As per patient or self-report, supports the patient in a professional role
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 14 2025
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04479605
Start Date
July 15 2020
End Date
May 14 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065